Document Detail


Lack of management of cardiovascular risk factors in type 2 diabetic patients.
MedLine Citation:
PMID:  17229179     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Effective management of diabetic patients includes comprehensive control for not only blood sugar, but also other cardiovascular risk factors. We assessed whether haemoglobin A1c (A1C) concentrations, blood pressure, low density lipoprotein (LDL) cholesterol levels and microalbuminuria were regularly measured in 281 patients with type 2 diabetes who received care for over 1 year in the Department of Family Medicine located in an urban area of Korea. Subsequently, in patients with A1C > 7%; blood pressure >130/80 mmHg; LDL cholesterol levels >100 mg/dl; or microalbuminuria, we evaluated the status of management for those cardiovascular risk factors. Physicians were most likely to measure A1C levels (98.6%), but less likely to measure microalbuminuria (56.2%), LDL cholesterol (73.7%), or blood pressure (74.4%). Patients whose A1C levels were above the goal (78.2%) were likely to receive optimal therapy. In contrast, only 21.1% of patients with uncontrolled blood pressure and 5.3% of patients with LDL cholesterol levels above the target range received optimal management. Of the 36 patients with microalbuminuria or overt proteinuria, 66.7% took angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Measurement of parameters indicating cardiovascular risk factors in type 2 diabetic patients was not optimal, particularly regular measurements for microalbuminuria and for controlling LDL-cholesterol and blood pressure. These findings indicate a need for greater education of comprehensive cardiovascular management in type 2 diabetic patients and their physicians.
Authors:
K E Yun; M J Park; H S Park
Related Documents :
8885949 - Acute response to inhaled nitric oxide in newborns with respiratory failure and pulmona...
2646069 - Two-dimensional echocardiographic evaluation of inferior vena cava, right ventricle, an...
2822879 - Resting and exercise blood pressure with atenolol, enalapril and a low-dose combination.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  International journal of clinical practice     Volume:  61     ISSN:  1368-5031     ISO Abbreviation:  Int. J. Clin. Pract.     Publication Date:  2007 Jan 
Date Detail:
Created Date:  2007-01-18     Completed Date:  2007-04-10     Revised Date:  2007-12-17    
Medline Journal Info:
Nlm Unique ID:  9712381     Medline TA:  Int J Clin Pract     Country:  England    
Other Details:
Languages:  eng     Pagination:  39-44     Citation Subset:  IM    
Affiliation:
Department of Family Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Albuminuria / therapy
Cholesterol, HDL
Diabetes Mellitus, Type 2 / therapy*
Diabetic Angiopathies / therapy*
Female
Hemoglobin A, Glycosylated / metabolism
Humans
Hypercholesterolemia / therapy
Hypertension / therapy
Male
Middle Aged
Risk Factors
Treatment Outcome
Chemical
Reg. No./Substance:
0/Cholesterol, HDL; 0/Hemoglobin A, Glycosylated

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Features of metabolic syndrome in non-diabetic Italians and Brazilians: a discriminant analysis.
Next Document:  Acute renal infarction: a 10-year experience.